Biofrontera Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	5	4	24	113	-	-
Market Cap Growth	-51.88%	-82.82%	-78.39%	-	-	-
Enterprise Value	5	8	-2	89	-8	31
PE Ratio	-	-0.21	-38.24	-3.00	-	-
PS Ratio	0.15	0.12	0.85	4.70	-	-
PB Ratio	-1.45	0.88	1.02	9.99	-	-
P/FCF Ratio	-0.32	-0.17	-1.51	-4.24	-	-
P/OCF Ratio	-0.32	-0.17	-1.51	-4.24	-	-
EV/Sales Ratio	0.15	0.24	-0.07	3.68	-0.43	1.18
EV/EBITDA Ratio	-0.38	-0.44	-2.55	-2.41	1.08	-3.79
EV/EBIT Ratio	-0.36	-0.42	4.69	-2.38	1.00	-3.51
EV/FCF Ratio	-0.31	-0.33	0.12	-3.32	0.65	-0.81
Debt / Equity Ratio	-0.68	1.13	0.06	-	-	-1.27
Debt / EBITDA Ratio	-0.18	-0.29	1.77	-	-	-4.69
Debt / FCF Ratio	-0.15	-0.22	-0.08	-	-	-1.00
Quick Ratio	0.54	0.36	1.68	2.67	2.57	1.03
Current Ratio	1.44	1.28	2.07	3.36	4.43	2.00
Asset Turnover	1.08	0.97	0.55	0.62	0.71	-
Interest Coverage	-11.54	-41.99	-2.12	-108.47	-2.81	-4.13
Return on Equity (ROE)	-1217.20%	-270.60%	-3.20%	-439.40%	90.20%	-
Return on Assets (ROA)	-74.80%	-57.10%	-1.20%	-97.50%	-41.50%	-
Return on Capital (ROIC)	1277.20%	-221.52%	-88.73%	-234.64%	-162.42%	-230.06%
Earnings Yield	-449.19%	-478.87%	-2.62%	-33.31%	-	-
FCF Yield	-478.16%	-592.32%	-66.35%	-23.61%	-	-
Buyback Yield / Dilution	-171.44%	-46.29%	-140.00%	-38330.37%	-2192.00%	-
Total Shareholder Return	-171.44%	-46.29%	-140.00%	-38330.37%	-2192.00%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).